VEGFA and myelodysplastic syndrome: There was no obvious difference between the gene expression of VEGFA (0.36 ± 0.39) in the IO MDS/AML group and the IO MDS group (0.39 ± 0.46) (p > 0.05) (Figure 4(d)).